Cargando…
Responsible use of negative research outcomes—accelerating the discovery and development of new antibiotics
Failure to share and make use of existing knowledge, particularly negative research outcomes, has been recognized as one of the key sources of waste and inefficiency in the drug discovery and development process. In the field of antibiotic research, providing a platform where negative outcomes could...
Autor principal: | Yu, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390367/ https://www.ncbi.nlm.nih.gov/pubmed/34272495 http://dx.doi.org/10.1038/s41429-021-00439-w |
Ejemplares similares
-
WIPO Re:Search: Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development
por: Manner, Cathyryne K., et al.
Publicado: (2019) -
Toward Autonomous Antibiotic Discovery
por: de la Fuente-Nunez, Cesar
Publicado: (2019) -
Bacterial Natural Product Drug Discovery for New Antibiotics: Strategies for Tackling the Problem of Antibiotic Resistance by Efficient Bioprospecting
por: Schneider, Yannik K.
Publicado: (2021) -
Drug discovery and development: Role of basic biological research
por: Mohs, Richard C., et al.
Publicado: (2017) -
Penicillin’s Discovery and Antibiotic Resistance: Lessons for the Future?
por: Lobanovska, Mariya, et al.
Publicado: (2017)